Personal information

Activities

Collapse all

Funding (2)

Complement evasion factor (CEF) - a novel candidate for the development of a vaccine against Group A Streptococcus.

2024 to 2027 | Contract
Marsden Fund (Wellington, NZ)
PROPOSAL_ID:

MFP-24-UOA-100

GRANT_NUMBER:

MFP-UOA2402
Source: check_circle
Royal Society Te Apārangi

Predicting the mutational trajectories behind viral zoonotic events

2024 to 2027 | Contract
Marsden Fund (Wellington, NZ)
PROPOSAL_ID:

MFP-23-UOW-006

GRANT_NUMBER:

MFP-UOW2301
Source: check_circle
Royal Society Te Apārangi

Peer review (3 reviews for 2 publications/grants)

Review activity for iScience. (1)
Review activity for Nature communications (2)
How many people are using ORCID?